查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726187

自动注射器市场规模、份额、趋势分析（按产品、适应症、最终用途、地区、细分市场预测），2025 年至 2030 年

Autoinjectors Market Size, Share & Trends Analysis By Product (Disposable, Reusable), By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes), By End-use (Home Care Settings, Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 160 Pages | 商品交期: 2-10个工作天内

价格

自动注射器市场的成长和趋势

根据Grand View Research, Inc.的最新报告，全球自动注射器市场规模预计到2030年将达到206亿美元，2025年至2030年期间的复合年增长率为15.1%。

随着自动注射器核准的增加，过敏性休克、糖尿病、风湿病和多发性硬化症等疾病的发生率不断上升，推动了自动注射器的成长。

预计危及生命的过敏症盛行率上升和对这些设备的需求增加将有助于这一增长。根据食物过敏研究和教育，每年约有 20 万人因食物过敏反应而寻求紧急医疗照护。

此外，预计核准的增加将推动成长。例如，2018年8月，美国FDA核准了梯瓦製药公司首个非专利肾上腺素自动注射器，用于治疗紧急过敏反应，包括过敏性休克。 0.15 毫克Epipen Jr 和 0.3 毫克Epipen学名药分别适用于体重 33 磅或以上的儿科患者和成人患者。

此外，製造商也在开发新产品和创新技术，预计这将推动市场成长。例如，2018年6月，日本艾伯维株式会社推出的全人源抗肿瘤坏死因子α单株抗体药物Humira，不仅具有锁定功能和注射开始/结束警报，还设有检查窗口，并在10秒内完成註射。这些设备是根据患者的接受度和依从性设计的，因此需求正在增加。随着技术的进步，预计它会变得更加方便和易于使用。这鼓励患者采用这项技术治疗慢性病。

自动注射器市场报告重点

  • 一次性自动注射器部分预计将在 2024 年占据 56.8% 的最大市场占有率，并在预测期内以最快的复合年增长率成长。可重复使用的自动注射器领域正在经历显着增长，这得益于患者对便利性和成本效益的偏好日益增加。
  • 2024 年，糖尿病领域占了最大的市场占有率，为 28.9%。预计多发性硬化症 (MS) 领域将在预测期内呈现最快的成长。
  • 预计到 2024 年，居家照护领域将占据最大的收益占有率，达到 54.1%，并且预计在预测期内将以最快的速度成长。预计医院诊所部门在预测期内也将显着成长。
  • 北美汽车注射器市场将主导全球市场，到 2024 年将占 45.3% 的收益占有率。美国汽车注射器市场在 2024 年占据北美汽车注射器产业的大部分份额。

目录

第一章调查方法与范围

第二章执行摘要

第 3 章自动注射器市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 自动注射器市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章 自动注射器市场：依产品的评估与趋势分析

  • 细分仪表板
  • 自动注射器市场：产品差异分析
  • 自动注射器市场产品前景
  • 2018-2030年市场规模、预测及趋势分析
  • 一次性自动注射器
  • 可重复使用的自动注射器

第五章自动注射器市场：依适应症的估计与趋势分析

  • 细分仪表板
  • 自动注射器市场：适应症变异分析
  • 自动注射器市场前景（依适应症划分）
  • 2018-2030年市场规模、预测及趋势分析
  • 类风湿性关节炎
  • 多发性硬化症
  • 糖尿病
  • 过敏反应
  • 其他的

第六章 自动注射器市场：依最终用途的估算与趋势分析

  • 细分仪表板
  • 自动注射器市场：最终用途差异分析
  • 自动注射器市场前景（按最终用途划分）
  • 2018-2030年市场规模、预测及趋势分析
  • 居家照护
  • 医院和诊所
  • 门诊手术中心

第七章 自动注射器市场：区域、估计与趋势分析

  • 区域仪表板
  • 区域汽车注射器市场波动分析
  • 自动注射器市场：按产品、适应症和最终用途的区域估计和趋势分析
  • 2018-2030年市场规模、预测及趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 市场参与企业分类
  • 2024年公司市场占有率分析
  • 主要企业简介
    • Eli Lilly
    • SHL Medical AG
    • AbbVie, Inc.
    • Amgen
    • Owen Mumford
    • Ypsomed
    • Teva Pharmaceutical
    • Biogen Idec
    • Mylan NV
    • Pfizer, Inc.
    • Sanofi
    • Gerresheimer AG
Product Code: GVR-3-68038-397-3

Autoinjectors Market Growth & Trends:

The global autoinjectors market size is expected to reach USD 20.6 billion by 2030, registering a CAGR of 15.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidence of anaphylactic shock and other diseases such as diabetes, rheumatoid, & multiple sclerosis along with increasing approvals of auto-injectors are impelling growth.

Increasing prevalence of life-threatening allergies and rising demand for these devices are expected to aid growth. As per the Food Allergy Research & Education, around 200, 000 people every year need emergency medical care for allergic food reactions.

In addition, increasing approvals are anticipated to drive growth. For instance, in August 2018, U.S. FDA approved the first generic epinephrine auto-injector of Teva Pharmaceuticals to treat emergency allergic reactions, including anaphylaxis. Generic versions of EpiPen Jr & EpiPen of 0.15 mg & 0.3 mg, respectively, are indicated for pediatric and adult patients weighing more than 33 pounds.

Moreover, manufacturers are also developing new products and innovative technologies, which is expected to propel market growth. For instance, in June 2018, AbbVie GK launched Humira, which is a fully human antitumor necrosis factor alpha monoclonal antibody formulation with lock function & injection start & end alerts as well as an inspection window and injects completely in 10 seconds. Demand for these devices is increasing as they are designed in accordance with patient acceptance and compliance. Technological advancements are anticipated to make them more convenient and user-friendly. This is encouraging patients to adopt this technology for chronic illnesses.

Autoinjectors Market Report Highlights:

  • The disposable autoinjectors segment accounted for the largest market share of 56.8% in 2024 and is expected to witness the fastest CAGR over the forecast period. The reusable auto injector segment is witnessing significant growth, driven by increasing patient preference for convenience and cost-effectiveness.
  • The diabetes segment accounted for the largest market share of 28.9% in 2024. The multiple sclerosis (MS) segment is expected to witness the fastest growth over the forecast period.
  • The homecare settings segment accounted for the largest revenue share of 54.1% in 2024 and is expected to witness the fastest growth over the forecast period. The hospitals and clinics segment is also expected to witness significant growth over the forecast period.
  • The North America autoinjectors market dominated the overall global market and accounted for the 45.3% revenue share in 2024. The autoinjectors market in the U.S. held a significant share of North America's auto-injectors industry in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.1. Segment Definitions
    • 1.1.1. Product
    • 1.1.2. Indication
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Indication outlook
    • 2.2.3. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Auto-Injectors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing prevalence of targeted therapies
      • 3.2.1.2. Increase in the incidence of anaphylactic shock
      • 3.2.1.3. Patients' preference to choose self-administration of injections
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Availability of its substitute products like general injections and oral tablets
  • 3.3. Auto-Injectors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Auto-Injectors Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Auto-Injectors Market: Product Movement Analysis
  • 4.3. Auto-Injectors Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Disposable Auto-Injectors
    • 4.5.1. Disposable Auto-Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Reusable Auto-Injectors
    • 4.6.1. Reusable Auto-Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.6.1.1. Prefilled Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.6.1.1.1. Prefilled Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.6.1.2. Empty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
        • 4.6.1.2.1. Empty Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Auto-Injectors Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Auto-Injectors Market: Indication Movement Analysis
  • 5.3. Auto-Injectors Market by Indication Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Rheumatoid Arthritis
    • 5.5.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Multiple Sclerosis
    • 5.6.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Diabetes
    • 5.7.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Anaphylaxis
    • 5.8.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.9. Other Therapies
    • 5.9.1. Other Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Auto-Injectors Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Auto-Injectors Market: End Use Movement Analysis
  • 6.3. Auto-Injectors Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Homecare Settings
    • 6.5.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Hospitals & Clinics
    • 6.6.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Ambulatory Surgical Centers
    • 6.7.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Auto-Injectors Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Auto-Injectors Market movement analysis
  • 7.3. Auto-Injectors Market: Regional Estimates & Trend Analysis by Product, Indication & End Use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. Europe Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. UK
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. UK Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Germany
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. Germany Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. France
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. France Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Italy
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Italy Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.6. Spain
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Spain Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.7. Denmark
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Denmark Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.8. Sweden
      • 7.6.8.1. Key Country Dynamics
      • 7.6.8.2. Competitive Scenario
      • 7.6.8.3. Regulatory Framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Sweden Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.9. Norway
      • 7.6.9.1. Key Country Dynamics
      • 7.6.9.2. Competitive Scenario
      • 7.6.9.3. Regulatory Framework
      • 7.6.9.4. Reimbursement scenario
      • 7.6.9.5. Norway Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Asia Pacific Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.2. Japan
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Japan Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.3. China
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. China Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.4. India
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. India Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.6. Australia
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Australia Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.7.7. Thailand
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Reimbursement scenario
      • 7.7.7.5. Thailand Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Latin America Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.2. Brazil
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Brazil Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Argentina Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9. Middle East & Africa
    • 7.9.1. Middle East & Africa Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.2. South Africa
      • 7.9.2.1. Key Country Dynamics
      • 7.9.2.2. Competitive Scenario
      • 7.9.2.3. Regulatory Framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. South Africa Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.3. Saudi Arabia
      • 7.9.3.1. Key Country Dynamics
      • 7.9.3.2. Competitive Scenario
      • 7.9.3.3. Regulatory Framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. Saudi Arabia Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.4. UAE
      • 7.9.4.1. Key Country Dynamics
      • 7.9.4.2. Competitive Scenario
      • 7.9.4.3. Regulatory Framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. UAE Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.9.5. Kuwait
      • 7.9.5.1. Key Country Dynamics
      • 7.9.5.2. Competitive Scenario
      • 7.9.5.3. Regulatory Framework
      • 7.9.5.4. Reimbursement scenario
      • 7.9.5.5. Kuwait Auto-Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Company Market Share Analysis, 2024
  • 8.3. Key Company Profiles
    • 8.3.1. Eli Lilly
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. SHL Medical AG
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. AbbVie, Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Amgen
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Owen Mumford
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Ypsomed
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Teva Pharmaceutical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Biogen Idec
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Mylan N.V.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. Pfizer, Inc.
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Sanofi
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Gerresheimer AG
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 4 Global auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Global auto-injectors market, by end use 2018 - 2030 (USD Million)
  • Table 6 North America auto-injectors market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 8 North America auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 9 North America auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S. auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 12 U.S. auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Canada auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Mexico auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe auto-injectors market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 21 Europe auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 22 Europe auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 24 UK auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 25 UK auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 27 Germany auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 28 Germany auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 30 France auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 31 France auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Italy auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 37 Spain auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Norway auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 39 Norway auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 40 Norway auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Sweden auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 42 Sweden auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 43 Sweden auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 45 Denmark auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 46 Denmark auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific auto-injectors market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 52 Japan auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Japan auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 55 China auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 56 China auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 58 India auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 59 India auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Australia auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 64 South Korea auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 65 South Korea auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 67 Thailand auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 68 Thailand auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America auto-injectors market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 71 Latin America auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 72 Latin America auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Brazil auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 78 Argentina auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa auto-injectors market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 85 South Africa auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 90 UAE auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 91 UAE auto-injectors market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait auto-injectors market, by product, 2018 - 2030 (USD Million)
  • Table 93 Kuwait auto-injectors market, by indication, 2018 - 2030 (USD Million)
  • Table 94 Kuwait auto-injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Auto-Injectors market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Auto-injectors market, type outlook key takeaways (USD Million)
  • Fig. 12 Auto-injectors market type movement analysis (USD Million), 2024 & 2030
  • Fig. 13 Disposable auto-injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Reusable auto-injectors market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Prefilled market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Empty market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Auto-injectors market, indication outlook key takeaways (USD Million)
  • Fig. 18 Auto-injectors market indication movement analysis (USD Million), 2024 & 2030
  • Fig. 19 Rheumatoid arthritis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Multiple sclerosis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Anaphylaxis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Other therapies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Auto-injectors market, end use outlook key takeaways (USD Million)
  • Fig. 25 Auto-injectors market end use movement analysis (USD Million), 2024 & 2030
  • Fig. 26 Homecare settings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Ambulatory surgical centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Auto-injectors market: Regional key takeaways (USD Million)
  • Fig. 30 Auto-injectors market regional outlook, 2024 & 2030, USD Million
  • Fig. 31 North America auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 U.S. auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Canada auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Europe auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 UK auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Germany auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 France auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Italy auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Asia Pacific auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 China auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Japan auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 India auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Thailand auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Latin America auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Brazil auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Argentina auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Middle East and Africa auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Africa auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Saudi Arabia auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 UAE auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Kuwait auto-injectors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 List of key emerging company's/indication disruptors/innovators